T1	Disease 107 155	Alzheimer's disease with cerebrovascular disease
T2	Disease 304 352	Alzheimer's disease with cerebrovascular disease
T3	Disease 354 362	AD + CVD
*	Equiv T2 T3
T4	Separation 1012 1094	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T5	Disease 1281 1289	AD + CVD
T6	Disease 1294 1314	age-matched controls
T7	FractionationFraction 1203 1210	soluble
T8	FractionationFraction 1215 1226	particulate
T9	Disease 1396 1404	AD + CVD
T10	FractionationFraction 1476 1483	soluble
T11	Disease 1496 1504	AD + CVD
T12	FractionationFraction 1584 1595	particulate
T13	Disease 1608 1616	AD + CVD
T14	FractionationFraction 1695 1702	soluble
T15	FractionationFraction 1923 1934	particulate
T16	Disease 1948 1956	AD + CVD
T17	Disease 2283 2291	AD + CVD
T18	CleavageAgent 8182 8215	sequencing-grade-modified trypsin
T19	Disease 8288 8296	AD + CVD
T20	Disease 8301 8328	healthy age-matched control
T21	Disease 8330 8334	Ctrl
*	Equiv T21 T20
T22	OrganismPart 8367 8387	middle temporal lobe
T23	OrganismPart 8389 8400	BA21 region
T24	Disease 8575 8583	AD + CVD
T25	SupplementaryFile 8728 8755	Additional file 1: Table S1
T26	NumberOfBiologicalReplicates 8757 8762	Three
T27	FractionationFraction 8860 8867	soluble
T28	FractionationFraction 8872 8883	particulate
T29	OrganismPart 9016 9033	BA21 brain region
T30	FractionationFraction 10291 10298	soluble
T31	FractionationFraction 10303 10314	particulate
T32	Separation 10334 10342	UC-ERLIC
T33	Separation 1096 1104	UC-ERLIC
*	Equiv T4 T33
T34	FractionationFraction 10343 10350	Soluble
T35	FractionationFraction 10355 10366	particulate
T36	Separation 10423 10505	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T37	Separation 10507 10515	UC-ERLIC
*	Equiv T36 T37
T38	CleavageAgent 11352 11381	In-solution tryptic digestion
T39	FractionationFraction 11406 11413	Soluble
T40	FractionationFraction 11422 11423	i
T41	CleavageAgent 11456 11485	in-solution tryptic digestion
T42	AlkylationReagent 11658 11672	dithiothreitol
T43	AlkylationReagent 11674 11677	DTT
*	Equiv T43 T42
T44	AlkylationReagent 11744 11757	iodoacetamide
T45	AlkylationReagent 11897 11900	DTT
T46	CleavageAgent 12037 12070	sequencing-grade-modified trypsin
T47	FractionationFraction 13148 13168	sarcosyl particulate
T48	CleavageAgent 13906 13939	sequencing-grade-modified trypsin
T49	AlkylationReagent 13540 13543	DTT
T50	Chromatography 14445 14459	PolyWAX column
T51	Chromatography 14517 14548	Shimadzu Prominence UFLC system
T52	Instrument 15295 15309	Orbitrap Elite
T53	Chromatography 15343 15376	Dionex UltiMate 3000 UHPLC system
T54	Chromatography 15485 15524	reverse phase Acclaim PepMap RSL column
T55	Instrument 16297 16311	Orbitrap Elite
T56	FragmentationMethod 16799 16835	high-energy collisional dissociation
T57	FragmentationMethod 16837 16840	HCD
*	Equiv T57 T56
T58	Modification 17294 17326	Carbamidomethylation of cysteine
A1	Modification T58 fixed
T59	FractionationFraction 17633 17644	particulate
T60	FractionationFraction 17964 17971	soluble
T61	FractionationFraction 17976 17987	particulate
T62	Disease 18152 18160	AD + CVD
T63	Disease 18483 18491	AD + CVD
T64	Disease 18936 18944	AD + CVD
